Clinical Trials Directory

Trials / Completed

CompletedNCT01871714

Phenotypic Properties in Individuals Affected With XLHED

Phenotypic Properties in Individuals Affected With X-linked Hypohidrotic Ectodermal Dysplasia: Symptoms and Facial Recognition

Status
Completed
Phase
Study type
Observational
Enrollment
30 (actual)
Sponsor
Edimer Pharmaceuticals · Industry
Sex
All
Age
4 Years
Healthy volunteers
Accepted

Summary

The current study design incorporates two previously developed, non-invasive approaches to characterize the phenotype of individuals affected with XLHED.

Detailed description

The current study design incorporates two previously developed, non-invasive approaches to characterize the phenotype of individuals affected with XLHED. Facial 3-dimensional (3D) imaging will be created from white-field morphometric scanning (Hammond, 2004. The 3D facial photographs collected from males (ages 4 years and up) will be used to develop a non-invasive screening tool, which could enable detection of craniofacial signs of XLHED in the newborn period. 3D facial profiling has been reported to be effective in identifying HED (Dellavia et al., 2008), but the technology does not yet meet the ease-of-use criteria for a universal screening tool. Standard 2-dimensional (2D) frontal and lateral facial photographs will be taken of the same XLHED-affected male subjects as well as of adult females (ages 18-45 yrs) at risk for being XLHED carriers and unaffected adult female controls. The 2D facial photographs will serve a dual purpose; the first being to beta-test a previously developed algorithm to identify males affected with XLHED (Automatic Phenotype Identification of XLHED Patients Final Report, December 25, 2012, unpublished), and the second to adapt the facial recognition algorithm to identify female carriers of XLHED.

Conditions

Timeline

Start date
2013-05-01
Primary completion
2013-07-01
Completion
2013-09-01
First posted
2013-06-07
Last updated
2013-11-27

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT01871714. Inclusion in this directory is not an endorsement.